The Discounted Cash Flow (DCF) valuation of Aurinia Pharmaceuticals Inc (AUP.TO) is (83.32) CAD. With the latest stock price at 16.76 CAD, the upside of Aurinia Pharmaceuticals Inc based on DCF is -597.1%.
Based on the latest price of 16.76 CAD and our DCF valuation, Aurinia Pharmaceuticals Inc (AUP.TO) is a sell. selling AUP.TO stocks now will result in a potential gain of 597.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 5.6% | 5.3% |
| Long-term Growth Rate | 3.0% - 4.7% | 3.9% |
| Fair Price | (472.82) - (46.43) | (83.32) |
| Upside | -2921.1% - -377.0% | -597.1% |